Abstract |
Previous studies indicate that the Sigma-1 ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) protects the brain from ischemia. Less clear is whether protection is mediated by agonism or antagonism of the Sigma-1 receptor, and whether drugs already in use for other indications and that interact with the Sigma-1 receptor might also prevent oxidative damage due to conditions such as cerebral ischemic stroke. The antipsychotic drug haloperidol is an antagonist of Sigma-1 receptors and in this study it potently protects against oxidative stress-related cell death in vitro at low concentrations. The protective potency of haloperidol and a number of other butyrophenone compounds positively correlate with their affinity for a cloned Sigma-1 receptor, and the protection is mimicked by a Sigma-1 receptor-selective antagonist (BD1063), but not an agonist (PRE-084). In vivo, an acute low dose (0.05 mg/kg s.c.) of haloperidol reduces by half the ischemic lesion volume induced by a transient middle cerebral artery occlusion. These in vitro and in vivo pre-clinical results suggest that a low dose of acutely administered haloperidol might have a novel application as a protective agent against ischemic cerebral stroke and other types of brain injury with an ischemic component.
|
Authors | John A Schetz, Evelyn Perez, Ran Liu, Shiuhwei Chen, Ivan Lee, James W Simpkins |
Journal | Brain research
(Brain Res)
Vol. 1181
Pg. 1-9
(Nov 21 2007)
ISSN: 0006-8993 [Print] Netherlands |
PMID | 17919467
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Neuroprotective Agents
- Receptors, sigma
- sigma-1 receptor
- Haloperidol
|
Topics |
- Animals
- Cells, Cultured
- Cerebral Infarction
(drug therapy, etiology)
- Dose-Response Relationship, Drug
- Female
- Haloperidol
(therapeutic use)
- Infarction, Middle Cerebral Artery
(complications)
- Neuroprotective Agents
(therapeutic use)
- Oxidative Stress
(drug effects)
- Rats
- Rats, Sprague-Dawley
- Receptors, sigma
(antagonists & inhibitors)
|